WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today announced the introduction of the Foreign Research Transparency Act of 2024, a bill requiring foreign sub-grantees to disclose all documents related to U.S. taxpayer-funded research.
This bill comes after EcoHealth Alliance and the Wuhan Institute of Virology refused to disclose materials related to a National… Read more »
WASHINGTON, D.C. – Today, U.S. Representatives Earl L. "Buddy" Carter (R-GA), Larry Buschon, MD (R-IN), and Diana Harshbarger (R-TN) introduced the 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act). This legislation establishes critical oversight and transparency of the 340B program - while providing clear,… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Nanette Barragán (D-CA), Darin LaHood (R-IL), and Paul Tonko (D-NY) today introduced the Accelerating Access to Dementia and Alzheimer’s Provider Training (AADAPT) Act, a bill that would provide Alzheimer’s and dementia education and training to more primary care providers, improving detection, diagnosis, and treatment of Alzheimer’s… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Lisa Blunt Rochester (D-DE), Greg Steube (R-FL), Terri Sewell (D-AL), Mariannette Miller-Meeks (R-IA), Jefferson Van Drew (R-NJ), and Joe Morelle (D-NY) today introduced the Telehealth Modernization Act of 2024 to permanently extend telehealth flexibilities for Medicare beneficiaries.
This bill will ensure permanent access to… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today issued the following statement after President Biden pushed for an expansion of the Inflation “Reduction” Act’s (IRA) government-controlled drug pricing mandates, which threaten the development of up to 342 cures and treatments and has already resulted in multiple cancer and rare-disease drugs being pulled from the… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) will attend Thursday’s State of the Union (SOTU) address with guest Jennelle Stephenson, a sickle cell disease (SCD) patient who received one of the first successful curative sickle cell treatments approved by FDA in December 2023.
Jennelle’s story highlights the life-saving miracle that is American medical innovation and… Read more »
WASHINGTON, D.C. - Reps. Earl L. "Buddy" Carter (R-GA), Nanette Barragán (D-CA), Diana Harshbarger (R-TN), and Vern Buchanan (R-FL) today introduced the Food and Drug Administration (FDA) Modernization Act 3.0, a bill that will facilitate the development, qualification, and adoption of testing methods that reduce or replace the use of animals in nonclinical testing.
The FDA… Read more »
WASHINGTON, D.C. - Reps. Earl L. “Buddy” Carter (R-GA), Nanette Barragán (D-CA), and Mariannette Miller-Meeks (R-IA) today celebrated the Biden administration’s decision to drop its appeal in a case against the patient community, keeping in effect the District of Columbia’s District Court ruling affirming the 2020 Notice of Benefit and Payment Parameters (NBPP) Final Rule… Read more »
WASHINGTON, D.C. – U.S. Representatives Earl L. “Buddy” Carter (R-GA), Kathy Castor (D-FL), John Joyce (R-PA), and Kim Schrier (D-WA) today introduced the Emergency Medical Services for Children (EMSC) Reauthorization Act of 2024, a critical piece of legislation that will ensure children receive appropriate health care during a medical emergency.
Established in 1984, EMSC is the only… Read more »
WASHINGTON, D.C. – This week, the Centers for Medicare and Medicaid Services (CMS) implemented a rule to allow Medicare Part B coverage of doctor-prescribed compression garments, the clinically recognized treatment for lymphedema. This rule was made possible by the passage of the Lymphedema Treatment Act, authored by U.S. Representatives Earl L. "Buddy" Carter (R-GA) and Jan… Read more »
